Skip to main content
TR

Treos Bio

London, United Kingdom
Last funding
$2.1M
Convertible NoteAug 2025

Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics.

Backed byThe Future FundLuminous VenturesBXR Partners LLP

About Treos Bio

How much funding has Treos Bio raised?

Treos Bio has raised $2.1M in total funding. The most recent round was Convertible Note. The last funding was announced in August 2025.

Who are Treos Bio's investors?

Treos Bio's investors include The Future Fund, Luminous Ventures, BXR Partners LLP.

Where is Treos Bio headquartered?

Treos Bio is headquartered in London, United Kingdom.

What does Treos Bio do?

Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics.

What stage is Treos Bio at?

Treos Bio is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Treos Bio — Funding & Investors." VCBacked, August 27, 2025, https://www.vcbacked.co/company/treos-bio. Accessed November 18, 2026.
APA
VCBacked. (2025). Treos Bio — Funding & Investors. Retrieved November 18, 2026, from https://www.vcbacked.co/company/treos-bio
Wikipedia (cite web)
{{cite web |title=Treos Bio — Funding & Investors |url=https://www.vcbacked.co/company/treos-bio |website=VCBacked |access-date=November 18, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Treos Bio? Request a listing update

Founder contacts
m***@treosbio.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →